Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 47451-47500 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05521490
Combating Physical Inactivity Pandemic in Kindergartens
NARecruiting
3,300 participants
Started: Aug 31, 2022 · Completed: Dec 31, 2026
2 conditions8 sponsors1 location
NCT05617547
Evaluating Pulse Oximetry Bias in Children With Darker Skin Pigmentation
N/ARecruiting
154 participants
Started: Aug 31, 2022 · Completed: Oct 1, 2024
2 conditions3 sponsors1 location
NCT05491005
The eHealth Diabetes Remission Trial
NARecruiting
106 participants
Started: Aug 31, 2022 · Completed: Dec 31, 2026
1 condition3 sponsors3 locations
NCT05535634
Sound Ear Check (SEC) in Hearing Diagnostics in Young Children
N/ARecruiting
100 participants
Started: Aug 31, 2022 · Completed: Dec 31, 2028
3 conditions1 sponsor1 location
NCT05245786
An Investigational Scan (64Cu-Labeled M5A Antibody) in Combination With SOC Chemotherapy and Radiotherapy in Locally Advanced Rectal Cancer
EARLY_PHASE1Recruiting
15 participants
Started: Aug 31, 2022 · Completed: Nov 12, 2025
5 conditions2 sponsors1 location
NCT05868109
Inhaled Nitric Oxide for Cardiac Arrest in Pediatrics and Adults (iNOCAPA)
PHASE2Recruiting
40 participants
Started: Aug 31, 2022 · Completed: Jan 31, 2026
1 condition2 sponsors4 locations
NCT05461482
CLINTERVENTIONAL Trial: Impact of Clinical Consultations and Audiovisual Tools in Interventional Radiology
NARecruiting
428 participants
Started: Aug 31, 2022 · Completed: Apr 30, 2024
5 conditions1 sponsor1 location
NCT06196307
Early Warning and Classification Model for Acute Non-traumatic Chest Pain
N/ARecruiting
188 participants
Started: Aug 30, 2022 · Completed: Jan 30, 2025
1 condition1 sponsor1 location
NCT06366815
phenotypeS in Non Ambulant Duchenne Muscular Dystrophy
N/ARecruiting
250 participants
Started: Aug 30, 2022 · Completed: Dec 30, 2025
3 conditions1 sponsor2 locations
NCT05338450
Clemastine Fumarate as Remyelinating Treatment in Internuclear Ophthalmoparesis and Multiple Sclerosis
PHASE3Recruiting
80 participants
Started: Aug 30, 2022 · Completed: Dec 31, 2027
2 conditions1 sponsor1 location
NCT05116475
Evaluation of dAroLutamide Addition to anDrogen Deprivation Therapy and radIatioN Therapy in Newly Diagnosed Prostate Cancer With Pelvic Lymph Nodes Metastases
PHASE3Recruiting
152 participants
Started: Aug 30, 2022 · Completed: Feb 28, 2027
1 condition2 sponsors1 location
NCT05508165
Patient Satisfaction of Virtual vs In-Person Workup and Treatment of Lower Urinary Tract Symptoms.
NARecruiting
60 participants
Started: Aug 30, 2022 · Completed: Dec 30, 2026
1 condition1 sponsor1 location
NCT05496491
Neoadjuvant Chemoradiotherapy and Consolidation Chemotherapy for Rectal Cancer: A Randomized Controlled Trial
NARecruiting
84 participants
Started: Aug 30, 2022 · Completed: Aug 30, 2026
1 condition1 sponsor1 location
NCT05428358
Incremental Value of Magnetic Resonance Imaging in Selection of Pancreatic Cancer Patients for Surgery
NARecruiting
200 participants
Started: Aug 30, 2022 · Completed: Dec 1, 2028
3 conditions4 sponsors4 locations
NCT05256875
An Analysis to Assess Non-adherence in People With Type 2 Diabetes
N/ARecruiting
600 participants
Started: Aug 30, 2022 · Completed: May 31, 2026
3 conditions1 sponsor2 locations
NCT05587205
Study to Assess Safety and Tolerability of EO2002
PHASE1Recruiting
32 participants
Started: Aug 30, 2022 · Completed: Dec 1, 2025
2 conditions2 sponsors1 location
NCT05456880
BEACON: A Study Evaluating the Safety and Efficacy of BEAM-101 in Patients With Severe Sickle Cell Disease
PHASE1/PHASE2Recruiting
15 participants
Started: Aug 30, 2022 · Completed: Feb 1, 2027
1 condition1 sponsor20 locations
NCT04877522
Asciminib Roll-over Study
PHASE4Recruiting
347 participants
Started: Aug 30, 2022 · Completed: Aug 30, 2030
2 conditions1 sponsor83 locations
NCT05271409
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease
PHASE3Recruiting
152 participants
Started: Aug 30, 2022 · Completed: Dec 31, 2028
1 condition2 sponsors82 locations
NCT05444465
Use of the REGENETEN™ Bioinductive Implant System in High Grade Partial-thickness Tears
NARecruiting
234 participants
Started: Aug 30, 2022 · Completed: Jun 30, 2028
1 condition1 sponsor20 locations
NCT05240651
Change in Stroke Volume Index After Diuresis for Patients With Decompensated Heart Failure
N/ARecruiting
50 participants
Started: Aug 30, 2022 · Completed: Jul 1, 2026
1 condition1 sponsor1 location
NCT05836831
Indian Trial of Tranexamic Acid in Spontaneous Intracerebral Haemorrhage
PHASE4Recruiting
3,400 participants
Started: Aug 30, 2022 · Completed: Nov 30, 2026
1 condition48 sponsors48 locations
NCT05492123
Nivolumab-ipilimumab and Chemoradiation for Cervical Cancer
PHASE2Recruiting
112 participants
Started: Aug 30, 2022 · Completed: Mar 31, 2028
1 condition3 sponsors14 locations
NCT05136703
Treatment Research Investigating Depression Effects on Neuroimmune Targets (TRIDENT)
NARecruiting
150 participants
Started: Aug 30, 2022 · Completed: Jul 31, 2027
3 conditions2 sponsors2 locations
NCT04987879
NASH AMPK Exercise Dosing (AMPED) Trial
NARecruiting
45 participants
Started: Aug 30, 2022 · Completed: Jul 15, 2026
1 condition1 sponsor1 location
NCT05549804
A Study of Intratumoral KL340399 in Patients with Advanced Solid Tumors
PHASE1Recruiting
30 participants
Started: Aug 30, 2022 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT05083182
A Study of Ustekinumab or Guselkumab in Pediatric Participants With Active Juvenile Psoriatic Arthritis
PHASE3Recruiting
48 participants
Started: Aug 30, 2022 · Completed: Aug 9, 2027
1 condition1 sponsor50 locations
NCT05394103
Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors
PHASE1/PHASE2Recruiting
130 participants
Started: Aug 30, 2022 · Completed: Aug 30, 2026
2 conditions2 sponsors11 locations
NCT05873322
Glucose Intolerance and Diabetes Related to Treatment With Steroids and PEG- Asparaginase in Children and Adolescents With ALL and Lymphoma
N/ARecruiting
100 participants
Started: Aug 30, 2022 · Completed: Dec 31, 2025
4 conditions1 sponsor1 location
NCT05149573
Investigation of PEMF Therapy for Female Patients With IC/BPS
NARecruiting
75 participants
Started: Aug 29, 2022 · Completed: Nov 30, 2025
3 conditions2 sponsors1 location
NCT05255003
STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated Thrombosis
PHASE4Recruiting
50 participants
Started: Aug 29, 2022 · Completed: Mar 31, 2025
2 conditions1 sponsor3 locations
NCT05417971
Reduced Intensity Fludarabine and TBI Prior to Haplo-Identical Transplantation
N/ARecruiting
20 participants
Started: Aug 29, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05334888
Sex-differential Host-microbiome CVD Risk - A Longitudinal Cohort Approach
N/ARecruiting
200 participants
Started: Aug 29, 2022 · Completed: Dec 31, 2027
4 conditions2 sponsors1 location
NCT05341557
A Phase 1 Study of BPI-371153 in Subjects with Advanced Solid Tumors or Relapsed/Refractory Lymphoma
PHASE1Recruiting
110 participants
Started: Aug 29, 2022 · Completed: Apr 30, 2027
4 conditions1 sponsor4 locations
NCT05534321
Prophylactic Radiotherapy of MInimally Symptomatic Spinal Disease
PHASE1/PHASE2Recruiting
74 participants
Started: Aug 29, 2022 · Completed: Sep 30, 2027
1 condition1 sponsor1 location
NCT05161819
Use Repetitive Transcranial Magnetic Stimulation to Treat Somatic Symptom Disorder
NARecruiting
30 participants
Started: Aug 29, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05423418
Safety, Tolerability, and Immunogenicity of ALFQ in a HIV Vaccine Containing A244 and B.65321 in Healthy Adults
PHASE1Recruiting
60 participants
Started: Aug 29, 2022 · Completed: Oct 23, 2028
2 conditions4 sponsors1 location
NCT05591937
S.T.A.N.D. Alacrity Center Signature Project
NARecruiting
1,000 participants
Started: Aug 29, 2022 · Completed: Apr 30, 2027
2 conditions1 sponsor1 location
NCT06044506
Autologous Natural Killer Cell Therapy for Hepatocellular Carcinoma
PHASE1Recruiting
3 participants
Started: Aug 29, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05626400
Clinical Study of Senl-T7 CAR T Cells in the Treatment of Relapsed and Refractory CD7+ Acute T-ALL/T-LBL
NARecruiting
100 participants
Started: Aug 29, 2022 · Completed: Dec 30, 2027
1 condition1 sponsor1 location
NCT05019664
Affixus Natural Nail System Humeral Nail PMCF
NARecruiting
100 participants
Started: Aug 29, 2022 · Completed: Aug 31, 2027
2 conditions1 sponsor4 locations
NCT05536609
Cast Or ePineural Suture for Digital Nerve Injuries - a Randomised Controlled Study
NARecruiting
166 participants
Started: Aug 29, 2022 · Completed: Sep 1, 2025
1 condition1 sponsor1 location
NCT05333458
Testing Atezolizumab With Selinexor in People ≥ 12 Years Old With Alveolar Soft Part Sarcoma, The AXIOM Trial
PHASE2Recruiting
27 participants
Started: Aug 29, 2022 · Completed: May 1, 2027
5 conditions1 sponsor13 locations
NCT05548296
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
PHASE2Recruiting
353 participants
Started: Aug 29, 2022 · Completed: Apr 30, 2027
1 condition2 sponsors69 locations
NCT05443087
TARGETed Therapy Drug MONITOring in DIGestive Oncology
NARecruiting
330 participants
Started: Aug 29, 2022 · Completed: Jun 30, 2027
5 conditions1 sponsor29 locations
NCT05222529
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Glycopyrronium (Bromide) in Children (6 to Less Than 12 Years) With Asthma
PHASE2Recruiting
42 participants
Started: Aug 29, 2022 · Completed: Aug 30, 2027
1 condition1 sponsor23 locations
NCT05422521
Radiomics and Metabolomics in the Follow-up of CAR T-cells for Refractory or Relapsed Non-Hodgkin's Lymphoma
NARecruiting
20 participants
Started: Aug 29, 2022 · Completed: Feb 28, 2026
1 condition1 sponsor1 location
NCT05355831
Patient-tailored Transcranial Direct Current Stimulation to Improve Stroke Rehabilitation
NARecruiting
22 participants
Started: Aug 28, 2022 · Completed: Dec 31, 2024
2 conditions5 sponsors3 locations
NCT06698055
Muscle Adaptations in Children and Adults Following Twelve Weeks of Flywheel or Weight Stack Resistance Exercise
NARecruiting
96 participants
Started: Aug 28, 2022 · Completed: Feb 9, 2025
7 conditions7 sponsors1 location
NCT04638582
Pembrolizumab as Neoadjuvant Therapy for Resectable Stage IA3 to IIA Non-Small Cell Lung Cancer (NSCLC)
PHASE2Recruiting
44 participants
Started: Aug 28, 2022 · Completed: Dec 27, 2025
1 condition1 sponsor1 location